13550_2018_358_MOESM5_ESM.tif (6.19 MB)
Additional file 5: Figure S3. of Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody
figure
posted on 2018-01-22, 05:00 authored by Yvonne Jauw, Marc Huisman, Tapan Nayak, Danielle Vugts, Randolph Christen, Valerie Naegelen, Dominik Ruettinger, Florian Heil, Adriaan Lammertsma, Henk Verheul, Otto Hoekstra, Guus van Dongen, C. Menke-van der Houven van OordtAdditional examples of focal tumour uptake of 89Zr-RG7356 at 96Â h p.i.. From left to right: low dose CT, attenuation-corrected PET and fused image. (a) Tumour lesion: left side of the skull (patient 8, 450Â mg cohort). (b) Tumour lesion: sacrum (patient 13, 675Â mg cohort). (TIFF 6335Â kb)
